Clinical Trial Update: Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase [Phase 4]

View source ↗

Summary

Phase 4 trial update on nilotinib as initial therapy for adults with Philadelphia chromosome/BCR-ABL-positive chronic myeloid leukemia in chronic phase; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: CML in Chronic Phase | Phase 4 | Status: COMPLETED | Results posted: 2017-02-24